3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Unknown
1
Not yet recruiting
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Intestinal Neoplasms
2
Colorectal Neoplasms
2
Papillomavirus Infections
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
CIN 2/3
1
Interventions
Oxaliplatin
3
Radiotherapy
2
Folfox protocol
2
Fluorouracil
2
Capecitabine
2
Bevacizumab
2
Artesunate
2
camrelizumab
1
apatinib
1
alectinib
1
XELOX
1
Trastuzumab
1
Ocoxin
1
Leucovorin
1
Irinotecan
1
Drug Therapy
1
Chemoradiotherapy
1
ABT-165
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2
×
Intestinal Neoplasms
×
Artesunate
×
Clear all
NCT07095309
2025-07-31
NeoART-M
Metanoic Health Ltd.
Phase 2
Not yet recruiting
120 enrolled
NCT02633098
2022-10-12
NeoART
St George's, University of London
Phase 2
Unknown
200 enrolled